Trump signs executive order imposing 100% tariff on some pharmaceutical drugs
The order targets imported brand-name drugs and is the latest move in the administration's push to reshore pharmaceutical manufacturing.
Supply Chain Dive · +13 outlets
Novo Nordisk cuts US price of Wegovy by half, and lowers China price
The cuts follow the White House weight-loss drug pricing announcement and signal an escalating price war in obesity medicines.
Meteo.gr · +14 outlets
Trump announces deals to cut weight-loss drug costs in Oval Office event
The announcement covers pricing arrangements for GLP-1 obesity drugs and drew immediate questions about how much patients will actually save.
www.polskieradio.pl · +13 outlets
CHMP backs Eli Lilly's oral GLP-1 Foundayo for obesity and type 2 diabetes in Europe
A positive EU opinion moves Lilly's obesity pill closer to approval in a market where oral GLP-1 competition is intensifying.
Pharmaceutical Executive · +9 outlets
Pfizer to halt development of closely watched weight-loss drug
Pfizer's exit from the program removes one of its main obesity pipeline bets and follows earlier disappointing trial results.
www.polskieradio.pl · +3 outlets
India's NPPA caps trade margins on 137 anti-cancer drugs at 30%, prices seen falling up to 70% from Nov 9
The margin cap applies across the distribution chain and is expected to sharply cut retail prices of the listed cancer medicines.
The Economic Times · +14 outlets
Compass Pathways' psilocybin drug hits primary endpoint in Phase 3 treatment-resistant depression trial
The late-stage win supports a regulatory filing for psilocybin therapy, with analysts pointing to potential approval by H1 2027.
Stocktwits · +8 outlets
FDA approves Opus Genetics' RYZUMVI phentolamine eye drops for presbyopia in adults
The approval covers the first eye drop for age-related near-vision loss, a condition affecting most US adults over 45.
Quiver Quantitative · +8 outlets
ImmunityBio's Anktiva wins expanded FDA approval in bladder cancer
The wider label expands use of the IL-15 agonist in non-muscle invasive bladder cancer, though the stock sold off on the news.
Simply Wall Street · +14 outlets
FDA approves Roche's Enspryng as first at-home injection for thyroid eye disease
The self-administered every-four-weeks option is the first at-home injectable approved for the condition.
Stock Titan · +10 outlets
Hanmi's Epe wins MFDS approval as South Korea's first homegrown GLP-1 obesity drug
The local approval is expected to intensify price competition in Korea's fast-growing obesity drug market.
코메디닷컴 · +2 outlets
FDA advisers narrowly vote to add six peptides to the drug compounding list
The close vote keeps compounded versions of popular peptides in play, with regulators still weighing the next steps.
The American Journal of Managed Care · +13 outlets
Capricor's deramiocel faces make-or-break FDA panel for Duchenne cell therapy
Investors are positioning around an imminent FDA decision on the Duchenne muscular dystrophy cell therapy after 24-month data presented in Japan.
Stocktwits · +3 outlets
Big Pharma chases Chinese biotech as obesity drug licensing deals surge
Multinational drugmakers are increasingly looking to China for obesity and metabolic pipeline assets as deal activity accelerates.
Chosunbiz · +9 outlets
Weight-loss drugmakers race for share of $100bn obesity market
Competition for the rapidly expanding obesity drug market is intensifying across manufacturers.
Sowetan · +3 outlets
Canada authorizes first generic weight-loss drug, pressuring pharmaceutical stocks
The approval opens the Canadian market to a lower-cost generic version of an established obesity medicine.
Meteo.gr · +3 outlets
Democrats allege Trump's pharma holdings gained as drugmakers won Medicare price negotiation carveouts
The allegation centers on financial gains tied to drug pricing policy decisions.
Fierce Pharma
Fractyl Health reports positive six-month REMAIN-1 results for Revita in post-GLP-1 weight maintenance
The pivotal cohort data supports a procedural option for patients seeking to keep weight off after stopping GLP-1 drugs.
Quiver Quantitative